Antibiotic resistance and bacterial profiles in an Iranian hospital (2018-2021)
The Journal of Infection in Developing Countries · 31.07.2026 · 20 (07) · 1013-1020
DOI: 10.3855/jidc.22384 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.07.2026. Verfasst von Hamid Malvirani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Dezful University of Medical Sciences, Dezful, Iran. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacteria, Bacterial Infections. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Antimicrobial resistance (AMR) poses a significant global health challenge, complicating the treatment of bacterial infections. This study investigated the prevalence of AMR among clinical isolates in an Iranian hospital from 2018 to 2021. Methodology: This four-year retrospective study was conducted at Ganjavian Hospital in Dezful, Iran. A total of 4,522 clinical specimens were analyzed. Bacterial identification and antimicrobial susceptibility testing were performed using standard microbiological methods and the Kirby-Bauer disk diffusion method, and interpreted per the Clinical and Laboratory Standards Institute (CLSI) guidelines. Statistical analysis included descriptive statistics, Chisquare tests for trend, and 95% confidence intervals (CIs) for resistance proportions.
Results
A total of 4,282 bacterial isolates were recovered; of which 78% were Gram-negative, with Enterobacterales constituting the predominant group (51.4%). Among Escherichia coli isolates, 72.3% (95% CI: 69.9–74.6%) were non-susceptible to ceftriaxone. The prevalence of multidrug-resistant (MDR) Enterobacterales was 41.4% (95% CI: 39.2–43.6%), with significant annual variation observed during the study period (χ² = 5.48, p < 0.001). Acinetobacter spp. exhibited high resistance to third-generation cephalosporins (94.1%; 95% CI: 91.1–96.2%). The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) was 29.7% (95% CI: 25.6–34.1%), and 40.0% of Enterococcus spp. were vancomycin-resistant.
Conclusions
The findings highlight the urgent need for enhanced infection-control and antimicrobial-stewardship programs. The high rates of resistance among common pathogens underscore the complexity of treating infections in critical care settings. This study emphasizes the necessity for surveillance and the development of targeted interventions to combat AMR, ensuring that effective treatment options remain available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Dezful University of Medical Sciences, Dezful, Iran.
- Infectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran.
- Department of Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Zitieren
APA
Malvirani, H., Deihim, B., & Kassani, A. (2026). Antibiotic resistance and bacterial profiles in an Iranian hospital (2018-2021). The Journal of Infection in Developing Countries, 20(07), 1013-1020. https://doi.org/10.3855/jidc.22384
Vancouver
Malvirani H, Deihim B, Kassani A. Antibiotic resistance and bacterial profiles in an Iranian hospital (2018-2021). The Journal of Infection in Developing Countries. 2026;20(07):1013-1020. doi:10.3855/jidc.22384
BibTeX
@article{Malvirani2026,
author = {Malvirani, Hamid and Deihim, Behnaz and Kassani, Aziz},
title = {Antibiotic resistance and bacterial profiles in an Iranian hospital (2018-2021)},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {07},
pages = {1013--1020},
doi = {10.3855/jidc.22384}
}
EUVIMED